Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	18.91B
Revenue (ttm)	11.04B
Net Income (ttm)	969.33M
Shares Out	1.15B
EPS (ttm)	0.84
PE Ratio	19.68
Forward PE	13.61
Dividend	0.35 (2.11%)
Ex-Dividend Date	Sep 17, 2025

Volume	12,110,221
Average Volume	14,413,870
Open	16.66
Previous Close	16.53
Day's Range	16.07 - 16.67
52-Week Range	12.96 - 18.96
Beta	0.41
RSI	55.06
Earnings Date	Oct 22, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.